Comparison of naftopidil and silodosin in the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia a randomized, crossover study

Comparison of naftopidil and silodosin in the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia : a randomized, crossover study

We compared the efficacy, safety, and patient preferences for two α1-adrenoceptor (AR) antagonists with different affinity for AR subtypes, naftopidil (Naf) and silodosin (Silo), for the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia (male LUTS/BPH). New...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 58(2012), 12 vom: 28. Dez., Seite 671-8
1. Verfasser: Masuda, Mitsunobu (VerfasserIn)
Weitere Verfasser: Jinza, Shin-ichirou, Masuko, Hiroshi, Asakura, Tomoyuki, Hashiba, Takafumi
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 2012
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Clinical Trial Comparative Study English Abstract Journal Article Randomized Controlled Trial Adrenergic alpha-Antagonists Indoles Naphthalenes Piperazines silodosin mehr... CUZ39LUY82 naftopidil R9PHW59SFN